Атеротромбоз

«REMEDIUM GROUP» Ltd.

Journal websitePeer review: Other
Evaluation status available after sign-in

About the journal

Атеротромбоз is an open-access journal published by «REMEDIUM GROUP» Ltd. in Russia, publishing in russian. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
«REMEDIUM GROUP» Ltd.
ISSN
2307-1109 · 2658-5952
Country
Russia
Languages
russian
Access
Open access
Articles in DOAJ
258
Declared review time
8 weeks
Declared peer-review model
other

Index listings

  • DOAJ · 2021-10-04
Indexing
DOAJ
APC
—
Declared review time (DOAJ)
8 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2024
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

258

Most recent article

2 years ago

Average review time (journal-declared via DOAJ)

8weeks

Works in OpenAlex

195

Last recorded publication year

2024

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

6

i10-index

1

From OpenAlex open data (CC0).

Editorial & policy8
Last DOAJ review date
2021-10-04
Added to DOAJ
2021-10-04
Declared plagiarism screening
Declared
Other fees beyond APC
No
Editorial board
Official page ↗
Open references deposited at Crossref
83%
ORCID iDs in current deposits
83%
Deposits licence metadata at Crossref
✓
Peer-review policy
View policy
Identity & continuity2
Alternate titles
Atherothrombosis
Source type
journal
Classification2

Subjects (DOAJ)

Medicine: Internal medicine

LCC codes

RC31-1245

Subject areas

  • Atrial Fibrillation Management and Outcomes
  • Atrial Fibrillation Management and Outcomes
  • Atrial Fibrillation Management and Outcomes
  • Venous Thromboembolism Diagnosis and Management
  • Venous Thromboembolism Diagnosis and Management
  • Blood Coagulation and Thrombosis Mechanisms
  • Venous Thromboembolism Diagnosis and Management
  • Antiplatelet Therapy and Cardiovascular Diseases
Show all subjects (75)
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Acute Myocardial Infarction Research
  • Coronary Interventions and Diagnostics
  • Acute Myocardial Infarction Research
  • Acute Myocardial Infarction Research
  • Acute Ischemic Stroke Management
  • Cardiac Arrhythmias and Treatments
  • Cardiac Arrhythmias and Treatments
  • Aortic aneurysm repair treatments
  • Platelet Disorders and Treatments
  • Aortic aneurysm repair treatments
  • Aortic aneurysm repair treatments
  • Cardiac Imaging and Diagnostics
  • Cardiac Imaging and Diagnostics
  • Abdominal vascular conditions and treatments
  • Aortic Disease and Treatment Approaches
  • Military Technology and Strategies
  • Linguistic, Cultural, and Literary Studies
  • Legal and Regulatory Analysis
  • Military Technology and Strategies
  • Linguistic, Cultural, and Literary Studies
  • Legal and Regulatory Analysis
  • COVID-19 Clinical Research Studies
  • Lipoproteins and Cardiovascular Health
  • Lipoproteins and Cardiovascular Health
  • Healthcare Systems and Public Health
  • Healthcare Systems and Public Health
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cardiac tumors and thrombi
  • Neurological Disorders and Treatments
  • Neurological Disorders and Treatments
  • Abdominal vascular conditions and treatments
  • Peripheral Artery Disease Management
  • Peripheral Artery Disease Management
  • Peripheral Artery Disease Management
  • Abdominal vascular conditions and treatments
  • Cardiovascular and Diving-Related Complications
  • Blood properties and coagulation
  • Lipoproteins and Cardiovascular Health
  • Aortic Disease and Treatment Approaches
  • Aortic Disease and Treatment Approaches
  • Infectious Aortic and Vascular Conditions
  • Cerebral Venous Sinus Thrombosis
  • Inflammatory Biomarkers in Disease Prognosis
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Cerebrovascular and Carotid Artery Diseases
  • Acute Ischemic Stroke Management
  • COVID-19 Clinical Research Studies
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Renal and Vascular Pathologies
  • Cerebrovascular and Carotid Artery Diseases
  • Acute Ischemic Stroke Management
  • COVID-19 Clinical Research Studies
  • Blood Pressure and Hypertension Studies
  • Renal and Vascular Pathologies
  • Renal and Vascular Pathologies
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Aortic Thrombus and Embolism
  • Vascular Procedures and Complications
  • Vascular Procedures and Complications
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Coronary Interventions and Diagnostics
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Coronary Interventions and Diagnostics
  • Cardiac Imaging and Diagnostics

Keywords (DOAJ)

  • atherosclerosis
  • acute coronary syndrome
  • acute cerebrovascular disorder
  • antithrombotic therapy
  • anticoagulants

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: